Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
Open | $1.500 |
Close | - |
Volume / Avg. | 28.453M / 9.142M |
Day Range | 1.250 - 1.520 |
52 Wk Range | 1.360 - 14.550 |
Market Cap | $373.793M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 17 |
Short Interest | 20.29% |
Days to Cover | 7.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Other companies in Pacific Biosciences’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by TD Cowen on Wednesday, April 17, 2024. The analyst firm set a price target for 2.50 expecting PACB to rise to within 12 months (a possible 79.21% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $1.395 last updated Today at April 17, 2024 at 3:10 PM EDT.
There are no upcoming dividends for Pacific Biosciences.
Pacific Biosciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.